Home
>
US Stocks
>
Omeros Corporation
Omeros Corporation
OMER

Omeros Corporation (OMER)

$6.4858.17%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.41
Today Low/High
6.25 / 6.49
52 Week Low/High
$9.25 / $23.85
P/E ratio
-6.5939
Market Cap
$919.31M

Company Details

Omeros is a commercial-stage biopharmaceutical company committed to discovering, developing and commercializing small-molecule and protein therapeutics for large-market and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system and immune-related diseases, including cancers. Its commercial product OMIDRIA® (phenylephrine and ketorolac intraocular solution) 1%/0.3% continues to gain market share in cataract surgery. Omeros' lead MASP-2 inhibitor narsoplimab targets the lectin pathway of complement and is the subject of a biologics license application under priority review by FDA for the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy. Narsoplimab is also in multiple late-stage clinical development programs focused on other complement-mediated disorders, including IgA nephropathy, atypical hemolytic uremic syndrome and COVID-19. OMS906, Omeros' inhibitor of MASP-3, the key activator of the alternative pathway of complement, is in a Phase 1 clinical trial, and the company's PDE7 inhibitor program OMS527, targeting addiction and movement disorders, has successfully completed a Phase 1 trial. Omeros' pipeline holds a diverse group of preclinical programs including a proprietary-asset-enabled antibody-generating technology and a proprietary GPCR platform through which it controls 54 GPCR drug targets and their corresponding compounds. One of these novel targets, GPR174, modulates a new cancer immunity axis recently discovered by Omeros, and the company is advancing GPR174-targeting antibodies and small-molecule inhibitors.
Organisation
Omeros Corporation
Headquaters
Seattle, Washington, US
Employees
277
Industry
Health Technology
CEO
Gregory Demopulos

Discover more

Frequently Asked Questions

What is Omeros Corporation (OMER) share price today?

Can Indians buy Omeros Corporation (OMER) shares?

How can I buy Omeros Corporation (OMER) shares from India?

Can Fractional shares of Omeros Corporation (OMER) be purchased?

What are the documents required to start investing in Omeros Corporation (OMER) stocks?

We are a SEBI registered investement advisor